Several years ago, we reviewed a paper suggesting that estrogen may be a beneficial treatment for women with schizophrenia. Â In this study, patients with schizophrenia were treated with estrogen. Â There was significant improvement in their [...]
Early observational studies suggested that postmenopausal hormone treatment may improve cognitive functioning in women; however, studies from the Women’s Health Initiative have shown that estrogen replacement therapy started in postmenopausal women (65 years or older) [...]
During pregnancy, many women complain that they feel more forgetful or less sharp than before their pregnancy.
There have long been concerns regarding the use of the anticonvulsant valproate (Depakote, VPA) during pregnancy. First trimester use of valproate has been associated with a 3-5% risk of neural tube defects, as well as an increased risk of other malformations affecting the heart and other organ systems. Multiple reports have also indicated that in utero exposure to valproate may also negatively affect cognitive development.
